Teva Pharmaceutical Financial Statements Trends

TEVA -- Israel Stock  

ILS 7,240  364.00  5.29%

This module enables investors to look at Teva Pharmaceutical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Operating Income of 2.9 B, Revenues of 19.7 B or Weighted Average Shares of 1 B, but also many exotic indicators such as Interest Coverage of 2.6166, Long Term Debt to Equity of 0.6617 or Calculated Tax Rate of 47.4652. This module is a perfect complement to use when analyzing Teva Pharmaceutical Valuation or Volatility. It can also complement various Teva Pharmaceutical Technical models. Also please take a look at analysis of Teva Pharmaceutical Correlation with competitors.
Revenues

Teva Pharmaceutical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets54.3 B92.9 B51.4 B
Increasing
Slightly volatile
Total Liabilities44.2 B59.6 B29.1 B
Increasing
Slightly volatile
Shareholders Equity33.2 B33.3 B24.3 B
Increasing
Slightly volatile
Current Assets18.4 B17 B14.6 B
Increasing
Slightly volatile
Current Liabilities13 B18.5 B12.1 B
Increasing
Slightly volatile

Teva Pharmaceutical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues19.7 B21.9 B17.7 B
Increasing
Slightly volatile
Net Income(11.1 B)329 M679.2 M
Decreasing
Slightly volatile
Weighted Average Shares1 B955 M880.4 M
Increasing
Slightly volatile
Weighted Average Shares Diluted960.5 M961 M890.6 M
Increasing
Slightly volatile
Operating Income2.9 B2.2 B2.6 B
Increasing
Stable

Teva Pharmaceutical Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow from Financing15.8 B25.2 B5.5 B
Increasing
Slightly volatile
Net Cash Flow from Investing(21.7 B)(35.7 B)(10.2 B)
Decreasing
Slightly volatile
Net Cash Flow from Operations4.2 B5.2 B4.2 B
Increasing
Slightly volatile

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share1.00530.071.8971
Decreasing
Slightly volatile
Earnings per Diluted Share(10.87)0.070.8783
Decreasing
Slightly volatile
Return on Average Equity(0.4434)1.04277.9289
Decreasing
Slightly volatile
Return on Average Assets0.02660.44724.1432
Decreasing
Slightly volatile
Gross Margin58.909954.143354.2941
Increasing
Slightly volatile
Profit Margin(0.5484)1.50219.8425
Decreasing
Slightly volatile
EBITDA Margin16.559612.121618.1454
Decreasing
Slightly volatile
Asset Turnover0.36170.29690.3912
Decreasing
Slightly volatile
Sales per Share24.135422.872420.3935
Increasing
Slightly volatile
Debt to Equity Ratio1541.073913.364
Increasing
Slightly volatile
Current Ratio0.940.91591.2366
Decreasing
Slightly volatile
Free Cash Flow per Share1.844.51543.5983
Increasing
Slightly volatile
Total Assets Per Share79.628991.517258.2228
Increasing
Slightly volatile
Cash Flow Per Share5.92295.14784.7296
Increasing
Slightly volatile
Return on Investment6.89123.95698.2004
Decreasing
Slightly volatile
Operating Margin16.329.834315.4655
Decreasing
Slightly volatile
Calculated Tax Rate47.465263.228222.0822
Increasing
Slightly volatile
Receivables Turnover3.7093.39363.3142
Increasing
Slightly volatile
Inventory Turnover2.23272.2522.0065
Increasing
Slightly volatile
PPandE Turnover3.15472.98873.3716
Decreasing
Slightly volatile
Cash and Equivalents Turnover5.15345.50628.293
Decreasing
Stable
Accounts Payable Turnover7.05597.59636.1535
Increasing
Slightly volatile
Interest Coverage2.61661.619511.8109
Decreasing
Slightly volatile
Long Term Debt to Equity0.66170.97560.4744
Increasing
Slightly volatile
Quick Ratio0.7390.45920.7133
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets4.3486(1.6773)6.2438
Decreasing
Slightly volatile
Revenue to Assets0.31470.23580.3627
Decreasing
Slightly volatile

Teva Pharmaceutical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings Before Interest Taxes and Depreciation Amortization EBITDA5.2 B2.7 B3.2 B
Increasing
Slightly volatile
Revenue Per Employee443 K383.5 K421.6 K
Increasing
Stable
Net Income Per Employee22.5 K5.8 K50.8 K
Decreasing
Slightly volatile

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Teva Pharmaceutical Fundamental Drivers

Teva Pharmaceutical Industries Limited Fundamental Market Drivers

Forward Price Earnings2,276.73
Average Daily Volume Last 10 Day1.13M
Average Daily Volume In Three Month659.2k
Fifty Day Average7,989.40
Two Hundred Day Average8,256.07
Also please take a look at analysis of Teva Pharmaceutical Correlation with competitors. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com